Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
                                         Target has curated data in GtoImmuPdb
  Target has curated data in GtoImmuPdb
                                        
                                        
                                        
                                        
                   
                                
                                
                            
                            
                            
                                
                        
Target id: 1886
Nomenclature: BAFF receptor
Abbreviated Name: BAFF-R
Systematic Nomenclature: TNFRSF13C
| Gene and Protein Information  | ||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference | 
| Human | 1 | 184 | 22q13.2 | TNFRSF13C | TNF receptor superfamily member 13C | |
| Mouse | 1 | 175 | 15 E1 | Tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | |
| Rat | - | - | Tnfrsf13c | TNF receptor superfamily member 13C | ||
| Database Links  | |
| Alphafold | Q96RJ3 (Hs), Q9D8D0 (Mm) | 
| ChEMBL Target | CHEMBL4630882 (Hs) | 
| Ensembl Gene | ENSG00000159958 (Hs), ENSMUSG00000068105 (Mm), ENSRNOG00000007664 (Rn) | 
| Entrez Gene | 115650 (Hs), 72049 (Mm), 500910 (Rn) | 
| Human Protein Atlas | ENSG00000159958 (Hs) | 
| KEGG Gene | hsa:115650 (Hs), mmu:72049 (Mm), rno:500910 (Rn) | 
| OMIM | 606269 (Hs) | 
| Pharos | Q96RJ3 (Hs) | 
| UniProtKB | Q96RJ3 (Hs), Q9D8D0 (Mm) | 
| Wikipedia | TNFRSF13C (Hs) | 
| Natural/Endogenous Ligands  | 
| BAFF {Sp: Human} | 
| Adaptor proteins (Human) | 
| TRAF3 | 
                            Download all structure-activity data for this target as a CSV file  
                        
| Antibodies | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Immunopharmacology Comments | 
| This is a type III membrane bound receptor for B cell activating factor (BAFF). BAFF enhances B cell survival and hence regulates the peripheral B cell population. It is suggested that overproduction of BAFF may enhance the survival of autoreactive B cells, an effect which may contribute in the pathogenesis of autoimmune diseases. The anti-BAFF receptor monoclonal antibody ianalumab (VAY736; Novartis) has progressed to clinical evaluation in autoimmune conditions and B cell malignancies. | 
| Immuno Disease Associations | ||||||||||
| 
 | ||||||||||
| 
 | ||||||||||
| 
 | 
1. Heusser C, Neugebauer J, Schaadt E, Urlinger S, Woisetschlaeger M. (2010) Compositions and methods of use for therapeutic antibodies. Patent number: WO2010007082A1. Assignee: Novartis. Priority date: 17/07/2008. Publication date: 21/01/2010.
2. Rahmanzadeh R, Weber MS, Brück W, Navardi S, Sahraian MA. (2018) B cells in multiple sclerosis therapy-A comprehensive review. Acta Neurol Scand, 137 (6): 544-556. [PMID:29512131]